Alterations of long-chain free fatty acid and magnesium concentrations in acute myocardial infarction
Sixteen patients with acute myocardial infarction were subjects of a study of the changes in plasma magnesium and long-chain free fatty acid (FFA) levels. In each patient, there was a sharp fall of magnesium levels and a sharp rise of FFA levels shortly after onset of pain. Magnesium and FFA values returned to normal within three days. An absolute fall in total magnesium level and a probable fall in magnesium ion concentration could be important factors in arrhythmias during the first two days. The simultaneous rise in FFA and fall in magnesium levels in a variety of pathologic and physiologic conditions affords an explanation for divergent changes in FFA and magnesium concentrations in acute myocardial infarction. The FFA rise appears to be the fall in magnesium levels, which has been previously unexplained.
Influence of oral magnesium supplementation on cardiac events among survivors of an acute myocardial infarction
Cardiovascular consequences of magnesium deficiency and loss: pathogenesis, prevalence and manifestations--magnesium and chloride loss in refractory potassium repletion
Platelet and plasma catecholamines in relation to plasma minerals and parathyroid hormone following acute myocardial infarction
Complementary vascular-protective actions of magnesium and taurine: a rationale for magnesium taurate
Correlation between divalent cation concentration and electrocardiogram in canine myocardial infarction
Adrenaline-induced changes in serum electrolytes, ECG, and blood pressure, with Ca-blockade pretreatment
Does exogenous magnesium suppress myocardial irritability and tachyarrhythmias in the nondigitalized patient?
Serum magnesium and potassium in acute myocardial infarction: relationship to existing beta-blockade and infarct size
Serum potassium concentration as a risk factor of ventricular arrhythmias early in acute myocardial infarction
Effect of magnesium deficiency on delta 6 desaturase activity and fatty acid composition of rat liver microsomes
One-year death rate in 270 patients with suspected acute myocardial infarction, initially treated with intravenous magnesium or placebo
Magnesium infusion reduces the incidence of arrhythmias in acute myocardial infarction. A double-blind placebo-controlled study
Serum N-3 polyunsaturated fatty acid levels correlate with the extent of coronary plaques and calcifications in patients with acute myocardial infarction
Effect of intravenous epinephrine on serum magnesium and free intracellular red blood cell magnesium concentrations measured by nuclear magnetic resonance
Hypothesis: possible role of magnesium and calcium in the development of structure and function of the plasma membrane in mammalian cells and in human diseases
Consequences of magnesium deficiency on the enhancement of stress reactions; preventive and therapeutic implications (a review)
Observations on serum and red blood cell magnesium changes in treadmill exercise-induced cardiac ischemia
Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.
Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.